Penicillium Notatum
Generic Name: penicillium notatum
Brand Names:
Symbio Not Drops
PURPOSE: For internal indications according to traditional homeopathic practice.
Overview
PURPOSE: For internal indications according to traditional homeopathic practice.
Uses
INDICATIONS: This remedy is indicated for symptoms associated with bacterial infections and inflammation according to traditional homeopathic practice.This includes those caused by staphylococci and streptococci.*
Dosage
DIRECTIONS: Take 5 – 10 drops orally, three times per day.
Interactions
ASK DOCTOR: Consult a physician if symptoms worsen or last for more than 7 days.
Warnings
WARNINGS: Do not use if the tamper evident strip is broken or removed from the base of the cap.
Pregnancy
If pregnant or breast feeding... If pregnant or breast feeding, ask a health professional before use.
Frequently Asked Questions
What is Penicillium Notatum used for?▼
INDICATIONS: This remedy is indicated for symptoms associated with bacterial infections and inflammation according to traditional homeopathic practice.This includes those caused by staphylococci and streptococci.*
Can I take Penicillium Notatum during pregnancy?▼
If pregnant or breast feeding... If pregnant or breast feeding, ask a health professional before use.
What are the important warnings for Penicillium Notatum?▼
WARNINGS: Do not use if the tamper evident strip is broken or removed from the base of the cap.
Related Medications
Fibrinolysin
fibrinolysin
Manufactured by PARKE DAVIS. Dosage form: OINTMENT. Route: TOPICAL. Active ingredients: CHLORAMPHENICOL (10MG/GM); DESOXYRIBONUCLEASE (666 UNITS/GM); FIBRINOLYSIN (1 UNITS/GM). Application: BLA050294.
Posaconazole Delayed-release
posaconazole delayed-release
Azole Antifungal [EPC]
11 DESCRIPTION Posaconazole is an azole antifungal agent. Posaconazole is available as delayed-release tablet intended for oral administration. Posaconazole is designated chemically as 4-[4-[4-[4-[[ (3 R ,5 R )-5- (2,4-difluorophenyl)tetrahydro-5- (1 H -1,2,4-triazol-1-ylmethyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-[(1 S ,2 S )-1-ethyl-2-hydroxypropyl]-2,4-dihydro-3 H -1,2,4-triazol-3-one with an empirical formula of C 37 H 42 F 2 N 8 O 4 and a molecular weight of 700.8.
Insulin Degludec
insulin degludec
Insulin Analog [EPC]
11 DESCRIPTION Insulin degludec is a long-acting basal human insulin analog for subcutaneous injection produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification. Insulin degludec differs from human insulin in that the amino acid threonine in position B30 has been omitted and a side-chain consisting of glutamic acid and a C16 fatty acid has been attached (chemical name: LysB29(Nε-hexadecandioyl-γ-Glu) des(B30) human insulin).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.